XRAY
DENTSPLY SIRONA Inc.
Company overview
- Market capitalization
- $1.85B
- Employees
- 14,000
- Latest publication
- 2026-09-29
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q1 20252025-03-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 898,000,000USD | 880,000,000USD | 961,000,000USD | 904,000,000USD | 879,000,000USD | 984,000,000USD | 953,000,000USD | 1,028,000,000USD |
| Cost Of Revenue | 405,000,000USD | 453,000,000USD | 518,000,000USD | 463,000,000USD | 413,000,000USD | 473,000,000USD | 447,000,000USD | 478,000,000USD |
| Gross Profit | 493,000,000USD | 427,000,000USD | 443,000,000USD | 441,000,000USD | 466,000,000USD | 511,000,000USD | 506,000,000USD | 550,000,000USD |
| Research Development | 45,000,000USD | 44,000,000USD | 40,000,000USD | 37,000,000USD | 36,000,000USD | 41,000,000USD | 42,000,000USD | 49,000,000USD |
| Selling General Administrative | 364,000,000USD | 353,000,000USD | 378,000,000USD | 358,000,000USD | 360,000,000USD | 401,000,000USD | 417,000,000USD | 418,000,000USD |
| Total Operating Expenses | 411,000,000USD | 397,000,000USD | 175,000,000USD | 395,000,000USD | 403,000,000USD | 461,000,000USD | 464,000,000USD | 470,000,000USD |
| Operating Income | 82,000,000USD | 30,000,000USD | 268,000,000USD | 46,000,000USD | 63,000,000USD | 50,000,000USD | 42,000,000USD | 80,000,000USD |
| Total Other Income Expense Net | -10,000,000USD | -72,000,000USD | -415,000,000USD | -276,000,000USD | -19,000,000USD | -16,000,000USD | -11,000,000USD | -34,000,000USD |
| Interest Expense | 22,000,000USD | 24,000,000USD | 22,000,000USD | 23,000,000USD | 19,000,000USD | 17,000,000USD | 18,000,000USD | 22,000,000USD |
| Income Before Tax | 72,000,000USD | -42,000,000USD | -147,000,000USD | -230,000,000USD | 44,000,000USD | 34,000,000USD | 31,000,000USD | 46,000,000USD |
| Income Tax Expense | 36,000,000USD | -32,000,000USD | -2,000,000USD | 198,000,000USD | 25,000,000USD | 38,000,000USD | 14,000,000USD | -39,000,000USD |
| Net Income | 36,000,000USD | -10,000,000USD | -146,000,000USD | -427,000,000USD | 20,000,000USD | -4,000,000USD | 18,000,000USD | 86,000,000USD |
| Minority Interest | -1,000,000USD | 0USD | -1,000,000USD | 1,000,000USD | 1,000,000USD | 0USD | 1,000,000USD | 1,000,000USD |
| Net Interest Income | — | -24,000,000USD | -22,000,000USD | -23,000,000USD | -19,000,000USD | -17,000,000USD | -18,000,000USD | -21,000,000USD |
| Tax Provision | — | -32,000,000USD | -2,000,000USD | 198,000,000USD | 25,000,000USD | 38,000,000USD | 14,000,000USD | -39,000,000USD |
| Net Income From Continuing Ops | — | -10,000,000USD | -145,000,000USD | -428,000,000USD | 19,000,000USD | -4,000,000USD | 17,000,000USD | 85,000,000USD |
| Ebit | — | -18,000,000USD | -125,000,000USD | -207,000,000USD | 71,000,000USD | 51,000,000USD | 49,000,000USD | 68,000,000USD |
| Ebitda | — | 61,000,000USD | -32,000,000USD | -115,000,000USD | 150,000,000USD | 137,000,000USD | 135,000,000USD | 154,000,000USD |
| Depreciation And Amortization | — | 79,000,000USD | 93,000,000USD | 92,000,000USD | 79,000,000USD | 86,000,000USD | 86,000,000USD | 86,000,000USD |
| Reconciled Depreciation | — | 79,000,000USD | 93,000,000USD | 92,000,000USD | 79,000,000USD | 86,000,000USD | 86,000,000USD | 86,000,000USD |
| Unclassified Operating Expenses | — | — | -243,000,000USD | — | 7,000,000USD | 16,000,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | 3,000,000USD | 5,000,000USD | 2,000,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | -38,000,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -15,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,680,000,000USD | 4,231,000,000USD | 3,339,000,000USD | 4,022,000,000USD | 3,986,300,000USD | 3,745,300,000USD | 2,674,300,000USD | 2,922,620,000USD |
| Cost Of Revenue | 1,840,000,000USD | 1,884,000,000USD | 1,683,000,000USD | 1,858,000,000USD | 1,918,500,000USD | 1,744,400,000USD | 1,157,100,000USD | 1,322,831,000USD |
| Gross Profit | 1,840,000,000USD | 2,347,000,000USD | 1,656,000,000USD | 2,164,000,000USD | 2,067,800,000USD | 2,000,900,000USD | 1,517,200,000USD | 1,599,789,000USD |
| Research Development | 150,000,000USD | 171,000,000USD | 123,000,000USD | 143,000,000USD | 160,500,000USD | 128,500,000USD | 74,900,000USD | 80,800,000USD |
| Selling General Administrative | 1,438,000,000USD | 1,551,000,000USD | 1,435,000,000USD | 1,723,500,000USD | 1,719,100,000USD | 1,523,000,000USD | 1,077,300,000USD | 1,143,106,000USD |
| Total Operating Expenses | 1,588,000,000USD | 1,739,000,000USD | 1,659,000,000USD | 1,811,000,000USD | 1,719,100,000USD | 1,523,000,000USD | 1,077,300,000USD | 1,143,106,000USD |
| Operating Income | 252,000,000USD | 608,000,000USD | -3,000,000USD | 353,000,000USD | -958,100,000USD | 454,700,000USD | 375,200,000USD | 445,600,000USD |
| Interest Expense | 88,000,000USD | 61,000,000USD | 62,000,000USD | 29,400,000USD | 37,300,000USD | 35,900,000USD | 55,900,000USD | 46,910,000USD |
| Net Interest Income | -88,000,000USD | -55,000,000USD | -48,000,000USD | -27,000,000USD | -35,200,000USD | -33,900,000USD | — | — |
| Income Before Tax | -486,000,000USD | 545,000,000USD | -50,000,000USD | 338,000,000USD | -958,400,000USD | 440,900,000USD | 329,700,000USD | 404,373,000USD |
| Income Tax Expense | 112,000,000USD | 134,000,000USD | 23,000,000USD | 82,000,000USD | 52,500,000USD | 9,500,000USD | 77,000,000USD | 81,120,000USD |
| Tax Provision | 112,000,000USD | 138,000,000USD | 23,000,000USD | 82,300,000USD | 52,500,000USD | 9,500,000USD | 77,000,000USD | — |
| Net Income | -598,000,000USD | 411,000,000USD | -73,000,000USD | 256,000,000USD | -1,011,000,000USD | 429,900,000USD | 251,200,000USD | 322,854,000USD |
| Net Income From Continuing Ops | -598,000,000USD | 421,000,000USD | -83,000,000USD | 263,100,000USD | -1,010,900,000USD | 431,400,000USD | 252,700,000USD | 323,253,000USD |
| Ebit | -398,000,000USD | 606,000,000USD | -4,000,000USD | 365,000,000USD | -916,100,000USD | 498,800,000USD | 456,400,000USD | 446,170,000USD |
| Ebitda | -46,000,000USD | 952,000,000USD | 330,000,000USD | 688,000,000USD | -585,300,000USD | 770,500,000USD | 579,300,000USD | 575,247,000USD |
| Depreciation And Amortization | 352,000,000USD | 346,000,000USD | 334,000,000USD | 323,000,000USD | 330,800,000USD | 271,700,000USD | 122,900,000USD | 129,077,000USD |
| Reconciled Depreciation | 352,000,000USD | 346,000,000USD | 334,000,000USD | 322,800,000USD | 330,800,000USD | — | — | — |
| Total Other Income Expense Net | -738,000,000USD | -63,000,000USD | -47,000,000USD | -15,000,000USD | -400,000USD | -13,800,000USD | -45,500,000USD | -41,227,000USD |
| Minority Interest | 0USD | 0USD | 3,000,000USD | 200,000USD | 100,000USD | 1,500,000USD | -100,000USD | 59,000USD |
| Non Operating Income Net Other | — | -8,000,000USD | — | 13,900,000USD | 37,000,000USD | 22,100,000USD | 8,800,000USD | 5,343,000USD |
| Net Income Applicable To Common Shares | — | 421,000,000USD | -83,000,000USD | 262,900,000USD | -1,011,000,000USD | 429,900,000USD | 251,200,000USD | 322,854,000USD |
| Unclassified Operating Expenses | — | — | 101,000,000USD | -55,500,000USD | -160,500,000USD | -128,500,000USD | -74,900,000USD | -80,800,000USD |
| Interest Income | — | — | 1,000,000USD | 2,400,000USD | 2,100,000USD | 2,000,000USD | 44,600,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,204,000,000USD | 5,229,000,000USD | 5,429,000,000USD | 5,653,000,000USD | 6,069,000,000USD | 6,050,000,000USD | 5,753,000,000USD | 6,626,000,000USD |
| Cash And Equivalents | 239,000,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,928,000,000USD | 1,845,000,000USD | 2,023,000,000USD | 2,072,000,000USD | 1,966,000,000USD | 1,978,000,000USD | 1,746,000,000USD | 1,921,000,000USD |
| Other Current Assets | 404,000,000USD | 374,000,000USD | 367,000,000USD | 369,000,000USD | 286,000,000USD | 364,000,000USD | 304,000,000USD | 335,000,000USD |
| Other Non Current Assets | 294,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 3,853,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,185,000,000USD | 1,207,000,000USD | 1,343,000,000USD | 1,405,000,000USD | 1,166,000,000USD | 1,793,000,000USD | 1,589,000,000USD | 1,542,000,000USD |
| Other Current Liabilities | 664,000,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 505,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,351,000,000USD | 1,318,000,000USD | 1,339,000,000USD | 1,478,000,000USD | 1,960,000,000USD | 2,010,000,000USD | 1,942,000,000USD | 2,491,000,000USD |
| Total Equity Including Noncontrolling Interest | 1,351,000,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 1,996,000,000USD | 2,006,000,000USD | 2,015,000,000USD | 2,017,000,000USD | 2,218,000,000USD | 1,593,000,000USD | 1,586,000,000USD | 1,795,000,000USD |
| Inventory | 665,000,000USD | 659,000,000USD | 642,000,000USD | 686,000,000USD | 675,000,000USD | 612,000,000USD | 564,000,000USD | 619,000,000USD |
| Property Plant Equipment Net | 974,000,000USD | 997,000,000USD | 1,000,000,000USD | 972,000,000USD | 979,000,000USD | 924,000,000USD | 902,000,000USD | 967,000,000USD |
| Goodwill | 1,138,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 870,000,000USD | 924,000,000USD | 974,000,000USD | 1,065,000,000USD | 1,133,000,000USD | 1,212,000,000USD | 1,207,000,000USD | 1,538,000,000USD |
| Accounts Payable | 260,000,000USD | 259,000,000USD | 300,000,000USD | 268,000,000USD | 268,000,000USD | 276,000,000USD | 241,000,000USD | 297,000,000USD |
| Short Term Debt | 228,000,000USD | 230,000,000USD | 360,000,000USD | 378,000,000USD | 184,000,000USD | 742,000,000USD | 595,000,000USD | 422,000,000USD |
| Common Stock | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Retained Earnings | -1,537,000,000USD | -1,574,000,000USD | -1,564,000,000USD | -1,385,000,000USD | -925,000,000USD | -848,000,000USD | -835,000,000USD | -374,000,000USD |
| Accumulated Other Comprehensive Income | -656,000,000USD | -655,000,000USD | -639,000,000USD | -672,000,000USD | -641,000,000USD | -659,000,000USD | -730,000,000USD | -638,000,000USD |
| Total Liab | — | 3,910,000,000USD | 4,089,000,000USD | 4,175,000,000USD | 4,108,000,000USD | 4,040,000,000USD | 3,810,000,000USD | 4,136,000,000USD |
| Other Current Liab | — | 688,000,000USD | 579,000,000USD | 671,000,000USD | 563,000,000USD | 738,000,000USD | 608,000,000USD | 798,000,000USD |
| Capital Stock | — | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Good Will | — | 1,142,000,000USD | 1,148,000,000USD | 1,270,000,000USD | 1,528,000,000USD | 1,632,000,000USD | 1,597,000,000USD | 1,937,000,000USD |
| Cash | — | 190,000,000USD | 326,000,000USD | 363,000,000USD | 359,000,000USD | 398,000,000USD | 272,000,000USD | 296,000,000USD |
| Cash And Short Term Investments | — | 190,000,000USD | 326,000,000USD | 363,000,000USD | 359,000,000USD | 398,000,000USD | 272,000,000USD | 296,000,000USD |
| Net Debt | — | 2,141,000,000USD | 2,142,000,000USD | 2,117,000,000USD | 2,135,000,000USD | 2,025,000,000USD | 2,000,000,000USD | 2,024,000,000USD |
| Short Long Term Debt | — | 230,000,000USD | 313,000,000USD | 378,000,000USD | 184,000,000USD | 742,000,000USD | 549,000,000USD | 422,000,000USD |
| Short Long Term Debt Total | — | 2,331,000,000USD | 2,468,000,000USD | 2,480,000,000USD | 2,494,000,000USD | 2,423,000,000USD | 2,272,000,000USD | 2,320,000,000USD |
| Net Receivables | — | 622,000,000USD | 688,000,000USD | 654,000,000USD | 646,000,000USD | 604,000,000USD | 606,000,000USD | 671,000,000USD |
| Property Plant Equipment Gross | — | 997,000,000USD | 2,572,000,000USD | 972,000,000USD | 979,000,000USD | 924,000,000USD | 2,243,000,000USD | 967,000,000USD |
| Common Stock Shares Outstanding | — | 199,900,000shares | 199,600,000shares | 199,500,000shares | 199,300,000shares | 199,800,000shares | 203,200,000shares | 201,000,000shares |
| Non Current Assets Total | — | 3,384,000,000USD | 3,406,000,000USD | 3,581,000,000USD | 4,103,000,000USD | 4,072,000,000USD | 4,007,000,000USD | 4,705,000,000USD |
| Non Current Liabilities Total | — | 2,703,000,000USD | 2,746,000,000USD | 2,770,000,000USD | 2,942,000,000USD | 2,247,000,000USD | 2,221,000,000USD | 2,594,000,000USD |
| Non Current Liabilities Other | — | 518,000,000USD | 544,000,000USD | 573,000,000USD | 523,000,000USD | 432,000,000USD | 415,000,000USD | 503,000,000USD |
| Non Currrent Assets Other | — | 321,000,000USD | 284,000,000USD | 274,000,000USD | 463,000,000USD | 304,000,000USD | 301,000,000USD | 70,000,000USD |
| Net Working Capital | — | 638,000,000USD | 680,000,000USD | 667,000,000USD | 800,000,000USD | 185,000,000USD | 157,000,000USD | 379,000,000USD |
| Unclassified Current Liabilities | — | -200,000,000USD | -283,000,000USD | -378,000,000USD | -142,000,000USD | -705,000,000USD | -499,000,000USD | -422,000,000USD |
| Unclassified Non Current Liabilities | — | 179,000,000USD | 187,000,000USD | 180,000,000USD | 201,000,000USD | 222,000,000USD | 220,000,000USD | 296,000,000USD |
| Unclassified Equity | — | 3,541,000,000USD | 3,536,000,000USD | 3,529,000,000USD | 3,520,000,000USD | 3,511,000,000USD | 3,501,000,000USD | 3,497,000,000USD |
| Current Deferred Revenue | — | — | 74,000,000USD | 88,000,000USD | 109,000,000USD | — | 95,000,000USD | 25,000,000USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | 193,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,429,000,000USD | 5,753,000,000USD | 7,370,000,000USD | 7,643,000,000USD | 9,239,000,000USD | 9,350,000,000USD | 8,603,000,000USD | 8,687,000,000USD |
| Intangible Assets | 974,000,000USD | 1,207,000,000USD | 1,705,000,000USD | 1,903,000,000USD | 2,319,000,000USD | 2,504,000,000USD | 2,176,000,000USD | 2,420,300,000USD |
| Other Current Assets | 367,000,000USD | 304,000,000USD | 259,000,000USD | 216,000,000USD | 195,000,000USD | 178,000,000USD | 205,000,000USD | 277,600,000USD |
| Total Liab | 4,089,000,000USD | 3,810,000,000USD | 4,076,000,000USD | 3,831,000,000USD | 4,242,000,000USD | 4,415,000,000USD | 3,508,000,000USD | 3,554,000,000USD |
| Total Stockholder Equity | 1,340,000,000USD | 1,942,000,000USD | 3,293,000,000USD | 3,811,000,000USD | 4,996,000,000USD | 4,932,000,000USD | 5,093,000,000USD | 5,120,900,000USD |
| Other Current Liab | 579,000,000USD | 613,000,000USD | 602,000,000USD | 583,000,000USD | 636,000,000USD | 598,000,000USD | 545,000,000USD | 549,600,000USD |
| Common Stock | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 2,600,000USD |
| Capital Stock | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD | 2,600,000USD | 2,600,000USD |
| Retained Earnings | -1,564,000,000USD | -835,000,000USD | 205,000,000USD | 456,000,000USD | 1,514,000,000USD | 1,198,000,000USD | 1,404,000,000USD | 1,225,900,000USD |
| Good Will | 1,148,000,000USD | 1,597,000,000USD | 2,438,000,000USD | 2,688,000,000USD | 3,976,000,000USD | 3,986,000,000USD | 3,397,000,000USD | 3,431,300,000USD |
| Cash | 326,000,000USD | 272,000,000USD | 334,000,000USD | 365,000,000USD | 339,000,000USD | 438,000,000USD | 405,000,000USD | 309,600,000USD |
| Cash And Short Term Investments | 326,000,000USD | 272,000,000USD | 334,000,000USD | 365,000,000USD | 339,000,000USD | 438,000,000USD | 405,000,000USD | 309,600,000USD |
| Total Current Assets | 2,023,000,000USD | 1,746,000,000USD | 1,973,000,000USD | 1,893,000,000USD | 1,852,000,000USD | 1,798,000,000USD | 2,000,000,000USD | 1,888,000,000USD |
| Total Current Liabilities | 1,343,000,000USD | 1,589,000,000USD | 1,425,000,000USD | 1,170,000,000USD | 1,261,000,000USD | 1,372,000,000USD | 995,000,000USD | 1,013,300,000USD |
| Current Deferred Revenue | 74,000,000USD | 95,000,000USD | 91,000,000USD | 84,000,000USD | 68,000,000USD | 53,000,000USD | 29,000,000USD | 29,300,000USD |
| Net Debt | 2,142,000,000USD | 2,000,000,000USD | 1,965,000,000USD | 1,782,000,000USD | 1,955,000,000USD | 2,017,000,000USD | 1,194,000,000USD | 1,347,700,000USD |
| Short Term Debt | 360,000,000USD | 595,000,000USD | 378,000,000USD | 172,000,000USD | 232,000,000USD | 347,000,000USD | 46,000,000USD | 92,400,000USD |
| Short Long Term Debt | 313,000,000USD | 549,000,000USD | 322,000,000USD | 118,000,000USD | 182,000,000USD | 299,000,000USD | 2,300,000USD | 92,400,000USD |
| Short Long Term Debt Total | 2,468,000,000USD | 2,272,000,000USD | 2,299,000,000USD | 2,147,000,000USD | 2,294,000,000USD | 2,455,000,000USD | 1,599,000,000USD | 1,657,300,000USD |
| Long Term Debt | 2,015,000,000USD | 1,586,000,000USD | 1,796,000,000USD | 1,826,000,000USD | 1,913,000,000USD | 1,978,000,000USD | 1,433,100,000USD | 1,564,900,000USD |
| Net Receivables | 688,000,000USD | 606,000,000USD | 756,000,000USD | 685,000,000USD | 803,000,000USD | 706,000,000USD | 828,000,000USD | 701,900,000USD |
| Inventory | 642,000,000USD | 564,000,000USD | 624,000,000USD | 627,000,000USD | 515,000,000USD | 476,000,000USD | 562,000,000USD | 598,900,000USD |
| Accounts Payable | 300,000,000USD | 241,000,000USD | 305,000,000USD | 279,000,000USD | 262,000,000USD | 302,000,000USD | 308,000,000USD | 283,900,000USD |
| Property Plant Equipment Net | 1,000,000,000USD | 902,000,000USD | 978,000,000USD | 961,000,000USD | 971,000,000USD | 967,000,000USD | 961,000,000USD | 870,600,000USD |
| Property Plant Equipment Gross | 2,572,000,000USD | 2,243,000,000USD | 2,343,000,000USD | 961,000,000USD | 966,000,000USD | 967,000,000USD | 961,700,000USD | 870,600,000USD |
| Accumulated Other Comprehensive Income | -639,000,000USD | -730,000,000USD | -636,000,000USD | -628,000,000USD | -592,000,000USD | -464,000,000USD | -600,000,000USD | -478,700,000USD |
| Common Stock Shares Outstanding | 199,400,000shares | 203,200,000shares | 212,000,000shares | 215,500,000shares | 220,200,000shares | 219,200,000shares | 224,400,000shares | 224,300,000shares |
| Non Current Assets Total | 3,406,000,000USD | 4,007,000,000USD | 5,397,000,000USD | 5,750,000,000USD | 7,387,000,000USD | 7,552,000,000USD | 6,603,000,000USD | 6,799,000,000USD |
| Non Current Liabilities Total | 2,746,000,000USD | 2,221,000,000USD | 2,651,000,000USD | 2,661,000,000USD | 2,981,000,000USD | 3,043,000,000USD | 2,513,000,000USD | 2,540,700,000USD |
| Non Current Liabilities Other | 544,000,000USD | 415,000,000USD | 502,000,000USD | 399,000,000USD | 525,000,000USD | 684,000,000USD | 599,800,000USD | 423,000,000USD |
| Non Currrent Assets Other | 284,000,000USD | 278,000,000USD | 48,000,000USD | 198,000,000USD | 121,000,000USD | 95,000,000USD | 69,000,000USD | 76,800,000USD |
| Net Working Capital | 680,000,000USD | 157,000,000USD | 548,000,000USD | 723,000,000USD | 651,000,000USD | 474,000,000USD | 1,004,400,000USD | 874,700,000USD |
| Unclassified Current Liabilities | -283,000,000USD | -504,000,000USD | -273,000,000USD | -66,000,000USD | -119,000,000USD | -227,000,000USD | 64,700,000USD | -34,300,000USD |
| Unclassified Non Current Liabilities | 187,000,000USD | 220,000,000USD | 353,000,000USD | -225,000,000USD | -404,000,000USD | -566,000,000USD | -469,000,000USD | -975,800,000USD |
| Unclassified Equity | 3,537,000,000USD | 3,501,000,000USD | 3,718,000,000USD | 3,977,000,000USD | 6,603,000,000USD | 6,601,000,000USD | 6,584,700,000USD | 6,519,500,000USD |
| Short Term Investments | — | — | 24,000,000USD | 24,000,000USD | 22,000,000USD | 33,000,000USD | 40,000,000USD | 28,200,000USD |
| Unclassified Current Assets | — | — | -24,000,000USD | -24,000,000USD | -22,000,000USD | -33,000,000USD | -40,000,000USD | -28,200,000USD |
| Unclassified Non Current Assets | — | — | 228,000,000USD | -198,000,000USD | -122,000,000USD | -270,000,000USD | -68,500,000USD | -76,800,000USD |
| Other Liab | — | — | — | 661,000,000USD | 933,000,000USD | 947,000,000USD | 949,100,000USD | 975,800,000USD |
| Other Assets | — | — | — | 198,000,000USD | 122,000,000USD | 270,000,000USD | 68,500,000USD | 76,800,000USD |
| Net Tangible Assets | — | — | — | -780,000,000USD | -1,252,000,000USD | -1,523,000,000USD | -480,300,000USD | -730,500,000USD |
| Deferred Long Term Liab | — | — | — | — | 14,000,000USD | — | — | 552,800,000USD |
| Treasury Stock | — | — | — | — | -2,535,000,000USD | -2,409,000,000USD | -2,301,300,000USD | -2,151,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 37,000,000USD | -10,000,000USD | -145,000,000USD | -427,000,000USD | -45,000,000USD | 19,000,000USD | -428,000,000USD | -495,000,000USD |
| Depreciation | 35,000,000USD | 79,000,000USD | 93,000,000USD | 93,000,000USD | 88,000,000USD | 79,000,000USD | 88,000,000USD | 89,000,000USD |
| Operating Cash Flow | 99USD | — | — | — | — | — | — | — |
| Capital Expenditures | -44USD | -52,000,000USD | -41,000,000USD | -39,000,000USD | -32,000,000USD | -19,000,000USD | -51,000,000USD | -43,000,000USD |
| Stock Based Compensation | — | 8,000,000USD | 8,000,000USD | 6,000,000USD | 9,000,000USD | 10,000,000USD | 4,000,000USD | 12,000,000USD |
| Other Non Cash Items | — | -21,000,000USD | 130,000,000USD | 260,000,000USD | 255,000,000USD | 9,000,000USD | 478,000,000USD | 502,000,000USD |
| Change To Account Receivables | — | 60,000,000USD | -35,000,000USD | -25,000,000USD | — | -31,000,000USD | 85,000,000USD | -67,000,000USD |
| Change To Inventory | — | -23,000,000USD | 44,000,000USD | -14,000,000USD | -21,000,000USD | -26,000,000USD | 15,000,000USD | 9,000,000USD |
| Change In Working Capital | — | 44,000,000USD | 29,000,000USD | -27,000,000USD | -113,000,000USD | -111,000,000USD | 61,000,000USD | 42,000,000USD |
| Total Cash From Operating Activities | — | 40,000,000USD | 101,000,000USD | 79,000,000USD | 48,000,000USD | 7,000,000USD | 87,000,000USD | 141,000,000USD |
| Free Cash Flow | — | -12,000,000USD | 60,000,000USD | 40,000,000USD | 16,000,000USD | -12,000,000USD | 36,000,000USD | 98,000,000USD |
| Investments | — | -7,000,000USD | -5,000,000USD | -36,000,000USD | -34,000,000USD | -17,000,000USD | -57,000,000USD | -47,000,000USD |
| Total Cashflows From Investing Activities | — | -53,000,000USD | -45,000,000USD | -36,000,000USD | -34,000,000USD | -17,000,000USD | -57,000,000USD | -47,000,000USD |
| Net Borrowings | — | -82,000,000USD | -62,000,000USD | -3,000,000USD | -26,000,000USD | 161,000,000USD | -1,000,000USD | 54,000,000USD |
| Total Cash From Financing Activities | — | -119,000,000USD | -99,000,000USD | -36,000,000USD | -68,000,000USD | 123,000,000USD | -38,000,000USD | -79,000,000USD |
| Dividends Paid | — | -32,000,000USD | -32,000,000USD | -32,000,000USD | -32,000,000USD | -32,000,000USD | -31,000,000USD | -33,000,000USD |
| Change In Cash | — | -136,000,000USD | -37,000,000USD | 4,000,000USD | -39,000,000USD | 126,000,000USD | -24,000,000USD | 17,000,000USD |
| Begin Period Cash Flow | — | 326,000,000USD | 363,000,000USD | 359,000,000USD | 398,000,000USD | 272,000,000USD | 296,000,000USD | 279,000,000USD |
| End Period Cash Flow | — | 190,000,000USD | 326,000,000USD | 363,000,000USD | 359,000,000USD | 398,000,000USD | 272,000,000USD | 296,000,000USD |
| Other Cashflows From Investing Activities | — | -1,000,000USD | -5,000,000USD | 4,000,000USD | -2,000,000USD | 1,000,000USD | -7,000,000USD | -12,000,000USD |
| Other Cashflows From Financing Activities | — | -5,000,000USD | -2,000,000USD | -1,000,000USD | 3,000,000USD | -6,000,000USD | -6,000,000USD | -100,000,000USD |
| Unclassified Operating Cash Flow | — | -60,000,000USD | -14,000,000USD | 174,000,000USD | -146,000,000USD | — | -116,000,000USD | -9,000,000USD |
| Unclassified Investing Cash Flow | — | 7,000,000USD | 6,000,000USD | 35,000,000USD | 34,000,000USD | 18,000,000USD | 58,000,000USD | 55,000,000USD |
| Sale Purchase Of Stock | — | — | 0USD | 0USD | — | — | 0USD | -100,000,000USD |
| Unclassified Financing Cash Flow | — | — | -3,000,000USD | — | -13,000,000USD | — | — | 100,000,000USD |
| Source | DisclosurePreliminaryAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -598,000,000USD | -910,000,000USD | -132,000,000USD | -950,000,000USD | -1,010,900,000USD | -1,573,300,000USD | 431,400,000USD | 251,100,000USD |
| Depreciation | 352,000,000USD | 349,000,000USD | 343,000,000USD | 328,000,000USD | 330,800,000USD | 316,400,000USD | 271,700,000USD | 122,900,000USD |
| Stock Based Compensation | 33,000,000USD | 39,000,000USD | 46,000,000USD | 59,000,000USD | 21,000,000USD | 48,000,000USD | 41,300,000USD | 25,600,000USD |
| Other Non Cash Items | 640,000,000USD | 1,024,000,000USD | 339,000,000USD | 1,386,000,000USD | 1,255,200,000USD | 2,076,400,000USD | -15,000,000USD | 43,900,000USD |
| Change To Account Receivables | -91,000,000USD | 104,000,000USD | -58,000,000USD | 85,000,000USD | 23,500,000USD | -63,400,000USD | -75,100,000USD | -900,000USD |
| Change To Inventory | -17,000,000USD | 17,000,000USD | 6,000,000USD | -141,000,000USD | -19,900,000USD | -62,900,000USD | 65,400,000USD | 32,100,000USD |
| Change In Working Capital | -222,000,000USD | 95,000,000USD | -89,000,000USD | -78,000,000USD | -33,200,000USD | -144,800,000USD | -43,200,000USD | 38,100,000USD |
| Total Cash From Operating Activities | 235,000,000USD | 461,000,000USD | 377,000,000USD | 517,000,000USD | 499,800,000USD | 601,900,000USD | 563,400,000USD | 497,400,000USD |
| Capital Expenditures | -131,000,000USD | -180,000,000USD | -149,000,000USD | -149,000,000USD | -188,000,000USD | -151,000,000USD | -126,100,000USD | -72,000,000USD |
| Free Cash Flow | 104,000,000USD | 281,000,000USD | 228,000,000USD | 368,000,000USD | 311,800,000USD | 450,900,000USD | 437,300,000USD | 425,400,000USD |
| Investments | -4,000,000USD | -197,000,000USD | -98,000,000USD | -138,000,000USD | 56,000,000USD | 4,000,000USD | -3,800,000USD | 72,100,000USD |
| Total Cashflows From Investing Activities | -132,000,000USD | -197,000,000USD | -89,000,000USD | -138,000,000USD | -253,300,000USD | -286,400,000USD | 60,000,000USD | -54,900,000USD |
| Net Borrowings | 70,000,000USD | 90,000,000USD | 119,000,000USD | -66,000,000USD | 51,000,000USD | -6,500,000USD | -877,500,000USD | -267,500,000USD |
| Total Cash From Financing Activities | -80,000,000USD | -302,000,000USD | -307,000,000USD | -329,000,000USD | -249,800,000USD | -400,800,000USD | -526,200,000USD | -302,900,000USD |
| Dividends Paid | -128,000,000USD | -126,000,000USD | -116,000,000USD | -104,000,000USD | -78,600,000USD | -78,300,000USD | -64,600,000USD | -40,000,000USD |
| Sale Purchase Of Stock | 0USD | -250,000,000USD | -300,000,000USD | -150,000,000USD | -250,000,000USD | -401,400,000USD | -813,900,000USD | -112,700,000USD |
| Change In Cash | 54,000,000USD | -62,000,000USD | -31,000,000USD | 26,000,000USD | -11,000,000USD | -63,300,000USD | 99,300,000USD | 133,000,000USD |
| Begin Period Cash Flow | 272,000,000USD | 334,000,000USD | 365,000,000USD | 339,000,000USD | 320,600,000USD | 383,900,000USD | 284,600,000USD | 151,600,000USD |
| End Period Cash Flow | 326,000,000USD | 272,000,000USD | 334,000,000USD | 365,000,000USD | 309,600,000USD | 320,600,000USD | 383,900,000USD | 284,600,000USD |
| Other Cashflows From Investing Activities | -1,000,000USD | -17,000,000USD | 47,000,000USD | -2,000,000USD | -179,300,000USD | -144,500,000USD | 399,500,000USD | -105,800,000USD |
| Other Cashflows From Financing Activities | -6,000,000USD | -16,000,000USD | -10,000,000USD | -73,000,000USD | 27,800,000USD | 82,300,000USD | 53,300,000USD | -33,400,000USD |
| Unclassified Operating Cash Flow | 30,000,000USD | -136,000,000USD | -130,000,000USD | -228,000,000USD | -63,100,000USD | -120,800,000USD | -122,800,000USD | 15,800,000USD |
| Unclassified Investing Cash Flow | 4,000,000USD | 197,000,000USD | 111,000,000USD | 151,000,000USD | 58,000,000USD | 5,100,000USD | -209,600,000USD | 50,800,000USD |
| Unclassified Financing Cash Flow | -16,000,000USD | — | — | 64,000,000USD | — | — | 1,176,500,000USD | 150,700,000USD |
| Change To Liabilities | — | — | — | 10,000,000USD | 3,000,000USD | 60,200,000USD | -12,700,000USD | -4,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 50,000,000USD | -11,000,000USD | -63,300,000USD | 99,300,000USD | 133,000,000USD |
| Exchange Rate Changes | — | — | — | — | -7,700,000USD | 22,000,000USD | 2,100,000USD | -6,600,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Americas | 316,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia Pacific | 130,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | EMEA | 452,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Connected Technology Solutions | 239,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Essential Dental Solutions | 376,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Orthodontic And Implant Solutions | 197,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Wellspect Healthcare | 86,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Americas | 330,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 115,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 435,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Connected Technology Solutions | 246,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Essential Dental Solutions | 350,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Orthodontic And Implant Solutions | 199,000,000 | USD | 0000818479-26-000149 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Wellspect Healthcare | 85,000,000 | USD | 0000818479-26-000149 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Connected Technology Solutions | 299,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Essential Dental Solutions | 372,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Orthodontic And Implant Solutions | 202,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Wellspect Healthcare | 88,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Connected Technology Solutions | 1,036,000,000 | USD | 0000818479-26-000075 |
| FY 2025Yearly · 2025-12-31 | Segment | Essential Dental Solutions | 1,469,000,000 | USD | 0000818479-26-000075 |
| FY 2025Yearly · 2025-12-31 | Segment | Orthodontic And Implant Solutions | 850,000,000 | USD | 0000818479-26-000075 |
| FY 2025Yearly · 2025-12-31 | Segment | Wellspect Healthcare | 325,000,000 | USD | 0000818479-26-000075 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 382,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Rest of World | 231,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 291,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Connected Technology Solutions | 259,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Essential Dental Solutions | 357,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Orthodontic And Implant Solutions | 205,000,000 | USD | 0000818479-25-000257 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Wellspect Healthcare | 83,000,000 | USD | 0000818479-25-000257 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 404,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Rest of World | 239,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 293,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Connected Technology Solutions | 243,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Essential Dental Solutions | 387,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Orthodontic And Implant Solutions | 226,000,000 | USD | 0000818479-25-000155 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Wellspect Healthcare | 80,000,000 | USD | 0000818479-25-000155 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Americas | 364,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 108,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 407,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Connected Technology Solutions | 235,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Essential Dental Solutions | 353,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Orthodontic And Implant Solutions | 217,000,000 | USD | 0000818479-26-000149 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Wellspect Healthcare | 74,000,000 | USD | 0000818479-26-000149 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Connected Technology Solutions | 293,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Essential Dental Solutions | 346,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Orthodontic And Implant Solutions | 185,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Wellspect Healthcare | 81,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Segment | Connected Technology Solutions | 1,062,000,000 | USD | 0000818479-26-000075 |
| FY 2024Yearly · 2024-12-31 | Segment | Essential Dental Solutions | 1,454,000,000 | USD | 0000818479-26-000075 |
| FY 2024Yearly · 2024-12-31 | Segment | Orthodontic And Implant Solutions | 973,000,000 | USD | 0000818479-26-000075 |
| FY 2024Yearly · 2024-12-31 | Segment | Wellspect Healthcare | 304,000,000 | USD | 0000818479-26-000075 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe | 347,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Rest of World | 230,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 374,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Connected Technology Solutions | 269,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Essential Dental Solutions | 369,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Orthodontic And Implant Solutions | 241,000,000 | USD | 0000818479-25-000257 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Wellspect Healthcare | 72,000,000 | USD | 0000818479-25-000257 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Europe | 387,000,000 | USD | 0000818479-25-000155 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Rest of World | 237,000,000 | USD | 0000818479-25-000155 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 360,000,000 | USD | 0000818479-25-000155 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Europe | 376,000,000 | USD | 0000818479-25-000056 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Rest of World | 221,000,000 | USD | 0000818479-25-000056 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 356,000,000 | USD | 0000818479-25-000056 |
| FY 2023Yearly · 2023-12-31 | Segment | Connected Technology Solutions | 1,169,000,000 | USD | 0000818479-26-000075 |
| FY 2023Yearly · 2023-12-31 | Segment | Essential Dental Solutions | 1,468,000,000 | USD | 0000818479-26-000075 |
| FY 2023Yearly · 2023-12-31 | Segment | Orthodontic And Implant Solutions | 1,040,000,000 | USD | 0000818479-26-000075 |
| FY 2023Yearly · 2023-12-31 | Segment | Wellspect Healthcare | 288,000,000 | USD | 0000818479-26-000075 |
| FY 2022Yearly · 2022-12-31 | Segment | Connected Technology Solutions | 1,219,000,000 | USD | 0000818479-25-000035 |
| FY 2022Yearly · 2022-12-31 | Segment | Essential Dental Solutions | 1,427,000,000 | USD | 0000818479-25-000035 |
| FY 2022Yearly · 2022-12-31 | Segment | Orthodontic And Implant Solutions | 1,006,000,000 | USD | 0000818479-25-000035 |
| FY 2022Yearly · 2022-12-31 | Segment | Wellspect Healthcare | 270,000,000 | USD | 0000818479-25-000035 |
| FY 2021Yearly · 2021-12-31 | Segment | Connected Technology Solutions | 1,348,000,000 | USD | 0000818479-24-000021 |
| FY 2021Yearly · 2021-12-31 | Segment | Essential Dental Solutions | 1,516,000,000 | USD | 0000818479-24-000021 |
| FY 2021Yearly · 2021-12-31 | Segment | Orthodontic And Implant Solutions | 1,064,000,000 | USD | 0000818479-24-000021 |
| FY 2021Yearly · 2021-12-31 | Segment | Wellspect Healthcare | 303,000,000 | USD | 0000818479-24-000021 |
| FY 2020Yearly · 2020-12-31 | Segment | Consumables | 1,385,000,000 | USD | 0000818479-23-000017 |
| FY 2020Yearly · 2020-12-31 | Segment | Technologies And Equipment | 1,954,000,000 | USD | 0000818479-23-000017 |
| FY 2020Yearly · 2020-12-31 | Geography | Germany | 439,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Foreign | 1,741,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Geography | SE | 53,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 1,109,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Dental Consumable Products | 1,337,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Dental Laboratory Products | 1,674,000,000 | USD | 0000818479-21-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Dental Speciality Products | 331,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Segment | Consumables | 1,746,000,000 | USD | 0000818479-22-000015 |
| FY 2019Yearly · 2019-12-31 | Segment | Technologies And Equipment | 2,283,000,000 | USD | 0000818479-22-000015 |
| FY 2019Yearly · 2019-12-31 | Geography | Germany | 478,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Foreign | 2,120,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Geography | SE | 56,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 1,375,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Product | Dental Consumable Products | 1,688,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Product | Dental Laboratory Products | 2,005,000,000 | USD | 0000818479-21-000007 |
| FY 2019Yearly · 2019-12-31 | Product | Dental Speciality Products | 336,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | Consumables | 1,818,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | Technologies And Equipment | 2,168,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Geography | Germany | 494,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Geography | Other Foreign | 2,167,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Geography | SE | 55,000,000 | USD | 0000818479-21-000007 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 1,270,000,000 | USD | 0000818479-21-000007 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.